Correlation Between Mink Therapeutics and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Mink Therapeutics and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Tarsus Pharmaceuticals.
Diversification Opportunities for Mink Therapeutics and Tarsus Pharmaceuticals
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mink and Tarsus is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mink Therapeutics and Tarsus Pharmaceuticals
Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the Tarsus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Mink Therapeutics is 1.15 times less risky than Tarsus Pharmaceuticals. The stock trades about -0.06 of its potential returns per unit of risk. The Tarsus Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 3,263 in Tarsus Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 1,982 from holding Tarsus Pharmaceuticals or generate 60.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mink Therapeutics vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Mink Therapeutics |
| Tarsus Pharmaceuticals |
Mink Therapeutics and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mink Therapeutics and Tarsus Pharmaceuticals
The main advantage of trading using opposite Mink Therapeutics and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |